Fuchs Petrolub SE FPE.DE · XETRA
38.60 € -0.39% (-0.15 €)
Summary
81 / 100 · Bulios Score
What speaks for it
- It earns 15 EUR a year on every 100 EUR of invested capital.
- It has raised its dividend 10 years in a row and pays out only 47% of profit.
- Out of every 100 EUR of revenue, 9.0 EUR is left as net profit.
- It holds more cash than debt: 190.0M € against 177.0M €.
What to watch
- It missed profit estimates 4 times in the last 8 quarters.
- Revenue growth is slowing: 1.5% a year over the last 3 years against 8.4% over 5 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 14.9 EUR for 1 EUR of yearly profit. Over the last five years it was 14.8 EUR on average.
Valuation in detailIs it growing?
SlowlyRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 8.4% a year over 5 years. Over the last 3 years it grew by 1.5% a year. For the next fiscal year analysts expect revenue to grow by 13%. Earnings per share grew by 7.8% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 EUR of revenue goes
- Cost of sales 65 EUR
- Research and development 2.3 EUR
- Sales and administration 20 EUR
- Taxes and other 3.9 EUR
- Net profit 9.0 EUR
Net profit, industry median (Chemicals - Specialty) 5.9 EUR
Out of every 100 EUR of revenue, 9.0 EUR is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 3.16%
- Paid out of profit
- 47%
- Raised in a row
- 10 years
You receive 1.22 € per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail